» Articles » PMID: 37162248

An Update on Adipose-Derived Stem Cells for Regenerative Medicine: Where Challenge Meets Opportunity

Overview
Journal Adv Sci (Weinh)
Date 2023 May 10
PMID 37162248
Authors
Affiliations
Soon will be listed here.
Abstract

Over the last decade, adipose-derived stem cells (ADSCs) have attracted increasing attention in the field of regenerative medicine. ADSCs appear to be the most advantageous cell type for regenerative therapies owing to their easy accessibility, multipotency, and active paracrine activity. This review highlights current challenges in translating ADSC-based therapies into clinical settings and discusses novel strategies to overcome the limitations of ADSCs. To further establish ADSC-based therapies as an emerging platform for regenerative medicine, this review also provides an update on the advancements in this field, including fat grafting, wound healing, bone regeneration, skeletal muscle repair, tendon reconstruction, cartilage regeneration, cardiac repair, and nerve regeneration. ADSC-based therapies are expected to be more tissue-specific and increasingly important in regenerative medicine.

Citing Articles

Enhancement of adipose stem cell quality via Cu-MON: Transcriptome and bioinformatics analysis of normal and diabetic stem cells.

Pang R, Liu K, Liu B, Yang J FASEB Bioadv. 2025; 7(3):e1485.

PMID: 40060943 PMC: 11886605. DOI: 10.1096/fba.2024-00153.


KLF5 enhances CXCL12 transcription in adipose-derived stem cells to promote endothelial progenitor cells neovascularization and accelerate diabetic wound healing.

Xie Y, Ni X, Wan X, Xu N, Chen L, Lin C Cell Mol Biol Lett. 2025; 30(1):24.

PMID: 40038579 PMC: 11877965. DOI: 10.1186/s11658-025-00702-0.


Adipose-derived stem cells enhance the tumorigenic potential of pre-malignant breast epithelial cells through paracrine activation of PI3K-AKT pathway.

Wu Q, He J, Herrler T, Yu B, Zhou Q, Zheng D Breast Cancer. 2025; .

PMID: 40019720 DOI: 10.1007/s12282-025-01686-7.


The promise of mesenchymal stromal/stem cells in erectile dysfunction treatment: a review of current insights and future directions.

Patel A, Shafie A, Mohamed A, Ali S, Tayeb F, Waggiallah H Stem Cell Res Ther. 2025; 16(1):98.

PMID: 40012076 PMC: 11866689. DOI: 10.1186/s13287-025-04221-9.


Amine-Functionalized Gellan Gum-Based Hydrogel Loaded with Adipose Stem Cell-Derived Small Extracellular Vesicles: An In Vitro Proof of Concept for Enhancing Diabetic Foot Ulcer Healing.

Tomasello L, Biondo M, Biscari G, Di Rosa L, Palumbo F, Fiorica C Gels. 2025; 11(2).

PMID: 39996662 PMC: 11854167. DOI: 10.3390/gels11020119.


References
1.
Takeo M, Lee W, Ito M . Wound healing and skin regeneration. Cold Spring Harb Perspect Med. 2015; 5(1):a023267. PMC: 4292081. DOI: 10.1101/cshperspect.a023267. View

2.
Kern S, Eichler H, Stoeve J, Kluter H, Bieback K . Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells. 2006; 24(5):1294-301. DOI: 10.1634/stemcells.2005-0342. View

3.
Zhu Y, Shi M, Monsel A, Dai C, Dong X, Shen H . Nebulized exosomes derived from allogenic adipose tissue mesenchymal stromal cells in patients with severe COVID-19: a pilot study. Stem Cell Res Ther. 2022; 13(1):220. PMC: 9135389. DOI: 10.1186/s13287-022-02900-5. View

4.
Liang W, Chen J, Li L, Li M, Wei X, Tan B . Conductive Hydrogen Sulfide-Releasing Hydrogel Encapsulating ADSCs for Myocardial Infarction Treatment. ACS Appl Mater Interfaces. 2019; 11(16):14619-14629. DOI: 10.1021/acsami.9b01886. View

5.
Varghese J, Griffin M, Mosahebi A, Butler P . Systematic review of patient factors affecting adipose stem cell viability and function: implications for regenerative therapy. Stem Cell Res Ther. 2017; 8(1):45. PMC: 5329955. DOI: 10.1186/s13287-017-0483-8. View